Apotheek Demapharm: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Demapharm
Largest movements
- Cash +€33,582
up €33,582 (+194%), from €17,326 to €50,909
mainly Depreciation (+€42,608) and Net result for the year (+€22,549)
- Tangible fixed assets -€30,641
down €30,641 (-14.3%), from €214,140 to €183,498
of which Land and buildings: -€15,569
- Stocks and contracts +€16,357
up €16,357 (+14.7%), from €111,087 to €127,444
- Intangible fixed assets -€11,967
no longer reported in 2025 (was €11,967)
- Receivables within one year -€9,339
down €9,339 (-24.0%), from €38,927 to €29,588
of which Other amounts receivable: -€6,880
- Profit (loss) carried forward +€22,549
up €22,549 (+26.3%), from -€85,902 to -€63,353
- Debts after one year -€14,882
down €14,882 (-9.7%), from €153,267 to €138,385
of which Financial debts: -€14,882
- Other debts -€8,859
down €8,859 (-5.9%), from €151,428 to €142,569
- Gross operating margin +€27,777
up €27,777 (+22.9%), from €121,535 to €149,312
- Depreciation -€6,875
down €6,875 (-13.9%), from €49,484 to €42,608
- Financial charges -€5,285
down €5,285 (-23.9%), from €22,107 to €16,822
- Staff costs -€4,644
down €4,644 (-6.8%), from €68,099 to €63,455
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €412,668 | €408,920 | -€3,748 | -0.9% |
| Fixed assets | 21/28 | €226,107 | €183,498 | -€42,608 | -18.8% |
| Intangible fixed assets | 21 | €11,967 | - | -€11,967 | |
| Tangible fixed assets | 22/27 | €214,140 | €183,498 | -€30,641 | -14.3% |
| Land and buildings | 22 | €165,265 | €149,697 | -€15,569 | -9.4% |
| Plant, machinery and equipment | 23 | €48,460 | €33,727 | -€14,733 | -30.4% |
| Furniture and vehicles | 24 | €415 | €75 | -€340 | -82.0% |
| Current assets | 29/58 | €186,562 | €225,422 | +€38,860 | +20.8% |
| Stocks and contracts in progress | 3 | €111,087 | €127,444 | +€16,357 | +14.7% |
| Stocks | 30/36 | €111,087 | €127,444 | +€16,357 | +14.7% |
| Amounts receivable within one year | 40/41 | €38,927 | €29,588 | -€9,339 | -24.0% |
| Trade receivables | 40 | €31,781 | €29,322 | -€2,459 | -7.7% |
| Other amounts receivable | 41 | €7,146 | €265 | -€6,880 | -96.3% |
| Cash at bank and in hand | 54/58 | €17,326 | €50,909 | +€33,582 | +194% |
| Deferred charges and accrued income | 490/1 | €19,221 | €17,481 | -€1,740 | -9.1% |
| Total equity and liabilities | 10/49 | €412,668 | €408,920 | -€3,748 | -0.9% |
| Equity | 10/15 | €47,489 | €70,038 | +€22,549 | +47.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €114,791 | €114,791 | = | 0.0% |
| Distributable reserves | 133 | €114,791 | €114,791 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€85,902 | -€63,353 | +€22,549 | +26.3% |
| Amounts payable | 17/49 | €365,179 | €338,882 | -€26,298 | -7.2% |
| Amounts payable after more than one year | 17 | €153,267 | €138,385 | -€14,882 | -9.7% |
| Financial debts | 170/4 | €118,267 | €103,385 | -€14,882 | -12.6% |
| Other amounts payable | 178/9 | €35,000 | €35,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €207,622 | €200,277 | -€7,345 | -3.5% |
| Current portion of amounts payable after more than one year | 42 | €14,589 | €14,882 | +€293 | +2.0% |
| Trade debts | 44 | €28,015 | €31,727 | +€3,712 | +13.2% |
| Suppliers | 440/4 | €28,015 | €31,727 | +€3,712 | +13.2% |
| Taxes, remuneration and social security | 45 | €13,590 | €11,099 | -€2,491 | -18.3% |
| Taxes | 450/3 | €3,185 | €1,396 | -€1,789 | -56.2% |
| Remuneration and social security | 454/9 | €10,405 | €9,703 | -€702 | -6.8% |
| Other amounts payable | 47/48 | €151,428 | €142,569 | -€8,859 | -5.9% |
| Accrued charges and deferred income | 492/3 | €4,291 | €220 | -€4,071 | -94.9% |
| Non-recurring operating income | 76A | - | €5,076 | +€5,076 | |
| Remuneration, social security and pensions | 62 | €68,099 | €63,455 | -€4,644 | -6.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €49,484 | €42,608 | -€6,875 | -13.9% |
| Other operating charges | 640/8 | €451 | €564 | +€113 | +25.0% |
| Non-recurring operating charges | 66A | - | €5,000 | +€5,000 | |
| Gross operating margin | 9900 | €121,535 | €149,312 | +€27,777 | +22.9% |
| Operating profit (loss) | 9901 | €3,501 | €37,684 | +€34,183 | +976% |
| Financial income | 75/76B | €2,340 | €2,068 | -€272 | -11.6% |
| Recurring financial income | 75 | €2,340 | €2,068 | -€272 | -11.6% |
| Financial charges | 65/66B | €22,107 | €16,822 | -€5,285 | -23.9% |
| Recurring financial charges | 65 | €22,107 | €16,822 | -€5,285 | -23.9% |
| Profit (loss) for the period before taxes | 9903 | -€16,266 | €22,930 | +€39,197 | |
| Income taxes | 67/77 | €359 | €381 | +€22 | +6.0% |
| Profit (loss) for the period | 9904 | -€16,625 | €22,549 | +€39,175 | |
| Profit (loss) for the period to be appropriated | 9905 | -€16,625 | €22,549 | +€39,175 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.